跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-400
首页
药物
M-400
M-400
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
IBUPROFEN CHEWABLE TABLET
申请人: SINO AMERICAN TIANJIN SMITHKLINE AND FRENCH LAB LTD
优先权: 2011
CN
EP
US
3 件公开
Hydrophilic organic copolymer and application thereof in skin protection field
申请人: SHENZHEN DINGSHENG ENTERPRISE MAN CO LTD
优先权: 2025
CN
DENTAL COMPOSITION AND COMPOSITE RESIN
申请人: KURARAY MEDICAL INC
优先权: 2008
US
Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof
申请人: UNIV SUN YAT SEN
优先权: 2007
CN
ALKYLENE CARBONATE PURIFICATION
申请人: KAHN ANDREW P
优先权: 2002
US
2 件公开
Self-nanoemulsion drug release system
申请人: JIANGSU KANION PHARMACEUTICAL CO LTD
优先权: 2023
CN
Process for the manufacture of particles containing antibotics and their application
申请人: HERAEUS KULZER GMBH
优先权: 2005
EP
Granules on the basis of pyrogenic titania, process for their preparation and use thereof
申请人: DEGUSSA
优先权: 1999
EP
药物
反馈